Cite
HARVARD Citation
Maouche, N. et al. (2021). Ixazomib, lenalidomide, and dexamethasone is effective and well tolerated in multiply relapsed (≥2nd relapse) refractory myeloma: a multicenter real world UK experience. Leukemia & lymphoma. 62 (6), pp. 1396-1404. [Online].